Development of a new EGFR antibody antagonist which exhibits potential biological effects against laryngeal cancer

BACKGROUND: Laryngeal cancer is a common malignant tumor of the head and neck. Clinical treatment methods mainly include radiotherapy and chemotherapy, but the toxicity and side effects of these treatments seriously affect the quality of life of patients. Currently, there are no specific anti-laryng...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Kai, Wang, Binquan, Qi, Qingyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267258/
https://www.ncbi.nlm.nih.gov/pubmed/34277764
http://dx.doi.org/10.21037/atm-21-1839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267258/
https://www.ncbi.nlm.nih.gov/pubmed/34277764
http://dx.doi.org/10.21037/atm-21-1839

Ejemplares similares